Informed-money record
NMTC · NEUROONE MEDICAL TECHNOLOGIES Corp
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
1
Bearish filings
10
Named actors
2
Disclosed $ (bull / bear)
$670K / $148K
Recent disclosures
11 of 11 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-06-30 | Market Development Director Christianson Mark | sold | $32K | SEC ↗ |
| 2026-06-30 | Officer (via Edward Jones) Christianson Mark | filed notice to sell | $33K | SEC ↗ |
| 2026-06-12 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-03-13 | Business Development Director Christianson Mark | sold | $80 | SEC ↗ |
| 2026-03-12 | Business Development Director Christianson Mark | sold | $654 | SEC ↗ |
| 2026-03-11 | Business Development Director Christianson Mark | sold | $2K | SEC ↗ |
| 2026-03-10 | Business Development Director Christianson Mark | sold | $9K | SEC ↗ |
| 2026-03-09 | Officer (via Edward Jones) Christianson Mark | filed notice to sell | $25K | SEC ↗ |
| 2026-03-01 | Chief Business Officer Wambeke David J. | bought | $670K | SEC ↗ |
| 2025-09-05 | Business Development Director Christianson Mark | sold | $22K | SEC ↗ |
| 2025-08-20 | Officer (via Edward Jones) Christianson Mark | filed notice to sell | $24K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals